Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis
Clinical trial NCT04676555 · COMPLETED
Trial details
- NCT number
- NCT04676555
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-11
- Primary completion
- 2021-10-21
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.